The Danish drugmaker said the accelerated approval was based on results from its Step Up trial, which showed 20.7% mean weight loss for participants with obesity.
Source link
About The Author
Novo Nordisk’s Higher Dose Wegovy Weight-Loss Drug Gains U.S. Approval